Telomir Pharmaceuticals Financial Statements 2022-2024 | TELO

Fifteen years of historical annual and quarterly income statements for Telomir Pharmaceuticals (TELO).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM20232022
$0.00$0$0
$0.00$0$0
$0.00$0$0
$2.07$1.57$0.83
$1.68$0.60$0.02
$-1.07$-1.77$0
$0.00$0$0
$-4.82$-3.94$-0.85
$-4.44$-9.13$0
$-9.25$-13.07$-0.85
$0.00$0$0
$-9.25$-13.07$-0.85
$0.00$0$0
$-9.25$-13.07$-0.85
$0.00$0$0
$-9.25$-13.07$-0.85
$-0.48$-2.33$-0.85
$-4.82$-3.94$-0.85
$-0.34$-0.48$-0.03
$-0.34$-0.45$-0.03

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2024-06-302024-03-312023-12-312023-06-302023-03-312022-12-31
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0.59$0.80$0$0.67$0.44$0
$0.88$0.74$0$0.06$0.04$0
$0$-0.37$0$-0.70$0$0
$0$0$0$0$0$0
$-1.47$-1.92$0$-1.43$-0.48$0
$0.03$-4.34$0$-0.12$0$0
$-1.45$-6.25$0$-1.55$-0.48$0
$0$0$0$0$0$0
$-1.45$-6.25$0$-1.55$-0.48$0
$0$0$0$0$0$0
$-1.45$-6.25$0$-1.55$-0.48$0
$0$0$0$0$0$0
$-1.45$-6.25$0$-1.55$-0.48$0
$-1.47$2.42$0$-1.43$-0.48$0
$-1.47$-1.92$0$-1.43$-0.48$0
$-0.05$-0.23$0$-0.06$-0.02$0
$-0.05$-0.23$0.00$-0.06$-0.02$0.00